Article - 
Limited access to UNIGEOther version: http://onlinelibrary.wiley.com/store/10.1046/j.1365-2133.2003.05209_12.x/asset/j.1365-2133.2003.05209_12.x.pdf?v=1&t=...
Highlights
More informations
Home
Titles listThe selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria
Titles listThe selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria
Scientific Article
unige:29787 
 |
The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria |
|
| Authors | ||
| Published in | British Journal of Dermatology. 2003, vol. 148, no. 3, p. 604-606 | |
| Keywords | Adult — Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use — Chronic Disease — Cyclooxygenase Inhibitors/*therapeutic use — Female — Histamine Release/drug effects — Humans — Lactones/*therapeutic use — Male — Middle Aged — Sulfones — Urticaria/*drug therapy | |
| Identifiers | PMID: 12653769 | |
| Full text |
Article - Limited access to UNIGE Other version: http://onlinelibrary.wiley.com/store/10.1046/j.1365-2133.2003.05209_12.x/asset/j.1365-2133.2003.05209_12.x.pdf?v=1&t=... |
|
| Citation (ISO format) | BOEHNCKE, Wolf-Henning et al. The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria. In: British Journal of Dermatology, 2003, vol. 148, n° 3, p. 604-606. https://archive-ouverte.unige.ch/unige:29787 |
189 hits 
0 download 
Contact an author
Update